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Purpose: Prostatic abscess is an uncommon urologic disease but has a high mortality 
rate if not treated properly. Furthermore, diagnosis and proper treatment of prostatic 
abscesses remains a challenge for physicians. Therefore, we compared data on con-
servative treatments, transurethral resection of prostatic abscess, and transrectal ul-
trasound (TRUS)-guided needle aspiration in 52 cases over a 10-year period. 
Materials and Methods: The records of 52 patients diagnosed with prostatic abscess 
by computed tomography at Gangnam Severance Hospital between January 2000 and 
September 2010 were retrospectively reviewed. All patients were discharged when 
their leukocytosis had normalized and they had been free of fever for 2 days. 
Multivariate regression analysis was done to determine independent risk factors for 
the length of hospitalization. 
Results: At the time of diagnosis, the average age of the 52 patients was 61.3 years 
(range, 33 to 81 years), the average volume of the prostate was 56.3 ml (range, 21 to 
223 ml), the average prostate-specific antigen was 18.54 ng/ml (range, 2.0 to 57.0 ng/ml), 
and the average abscess size was 3.8 cm (range, 2.1 to 5.5 cm). All patients were treated 
with parenteral antibiotics during their hospital stay with intravenous antibiotics 
(fluoroquinolone monotherapy or 3rd-generation cephalosporin in combination with 
an aminoglycoside). Of 52 patients, 22 had diabetes mellitus (42.3%), 19 had hyper-
tension (36.5%), and 7 (13.5%) had paraplegia due to spinal cord injury. The most com-
mon symptoms were fever (47, 90.4%), perineal discomfort (43, 82.7%), dysuria (40, 
76.9%), and urinary retention (29, 55.8%). Prostatic abscesses were treated by con-
servative treatment (11 cases), transurethral resection of prostatic abscess (23 cases), 
and TRUS-guided needle aspiration (18 cases). The average hospitalization stay was 
17.5 days (range, 6 to 39 days); that of conservative treatment patients was 19.1 days 
(range, 9 to 39 days). Patients treated by transurethral resection of prostatic abscess 
and TRUS-guided needle aspiration stayed 10.2 days (range, 6 to 15 days) and 23.25 
days (range, 18 to 34 days), respectively. Of the 18 cases who underwent needle aspira-
tion, prostatic abscesses recurred in 4 cases (22.2%) within 1 month after patient 
discharge. The 2 patients subjected to conservative treatment died due to sepsis. We 
found no independent factors that affected the average hospitalization period.
Conclusions: Patients with prostatic abscess treated by transurethral resection of the 
prostate had a significantly shorter hospitalization length compared with needle 
aspiration.
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INTRODUCTION
Prostatic abscess is a rare clinical occurrence in the anti-
biotic era and is difficult to diagnose because clinical pre-
sentations may mimic several other diseases of the lower 
urinary tract, such as dysuria, urgency, and frequency. In 
particular, differential diagnosis between acute bacterial 
prostatitis and prostatic abscess is difficult on the basis of 
clinical symptoms and examinations [1,2]. Prostatic ab-
scess has a high mortality rate if adequate and proper treat-
ment does not take place. It may result in severe complica-
tions and even urosepsis and death [3]. Therefore, diag-
nosis and proper treatment of prostatic abscess remains a 
challenge for physicians. 
Once clinical suspicion of prostatic abscess is estab-
lished, parenteral or oral administration of antibiotics and 
a surgical drain are needed to diminish severe complica-
tions [4]. Traditionally, an open perineal drain or transure-
thral resection of the prostatic abscess is used [5-7]; nowa-
days, a minimally invasive procedure like transrectal ul-
trasound (TRUS)-guided needle aspiration is preferable 
[8-10].
There are few reports about which treatment is more ef-
fective for prostatic abscess. In this study, we compared 
three groups of data on conservative treatment, transure-
thral resection of prostatic abscess, and TRUS-guided nee-
dle aspiration at the point of hospitalization stay and the 
recurrence rate in 52 cases over a 10-year period.
MATERIALS AND METHODS
1. Patients
Our retrospective study covered a period of 10 years be-
tween January 2000 and September 2010. During this pe-
riod, 52 patients at our hospital were diagnosed with pro-
static abscesses by use of computed tomography (CT). 
Patients with clinically suspicious prostatic abscesses who 
were not evaluated by CT were excluded. The data were col-
lected retrospectively from the medical records. 
2. Clinical features
All cases included a medical history, physical examination, 
several blood tests with culture, and urine analysis with 
culture. Prostatic abscesses were diagnosed with CT. All 
patients were initially treated with parenteral antibiotics 
during their hospital stay: either intravenous fluoroqui-
nolone monotherapy or third-generation cephalosporin in 
combination with an aminoglycoside. A suprapubic Foley 
catheter was left indwelling if patients experienced uri-
nary retention. All patients were treated in the hospital un-
til their leukocytosis was normalized and they had been 
free of fever for 2 days. Transurethral resection of prostatic 
abscess was performed under general anesthesia and nee-
dle aspiration was performed transperineally under local 
anesthesia with TRUS guidance by a radiologist. 
3. Statistical analysis
Statistical analysis was performed by using SPSS ver. 18.0 
(SPSS Inc., Chicago, IL, USA) software. The significance 
of differences in age, prostate volume, and prostate-specific 
antigen (PSA) concentration among groups on the basis of 
treatment methods was examined by using the Kruskal- 
Wallis test with the Dunn post hoc test. Fisher’s exact test 
was used to compare categorical variables (e.g., clinical 
symptoms). The data are expressed as the mean±standard 
deviation or median and range. Multiple linear regression 
analysis was done to determine independent risk factors 
for the length of hospitalization in patients with prostatic 
abscesses. All p-values less than 0.05 were considered stat-
istically significant.
RESULTS
The demographic and clinical features of the 54 patients 
with prostatic abscesses according to treatment method 
are shown in Table 1. At the time of diagnosis, the mean 
age of the patients was 61.34 years (range, 33 to 81 years). 
Of 52 patients, 22 (42.3%) had diabetes mellitus, 19 (36.5%) 
had hypertension, and 7 (13.5%) had paraplegia due to spi-
nal cord injury. There were no significant differences in the 
distribution of ages or the history of hypertension and dia-
betes mellitus between the three treatment groups of con-
servative treatment, transrectal resection of the prostate, 
and TRUS-guided needle aspiration. The most common 
symptoms were fever (47, 90.4%), perineal discomfort (43, 
82.7%), dysuria (40, 76.9%), and urinary retention (29, 
55.8%). Some patients experienced myalgia (18, 34.6%) 
and gross hematuria (9, 17.3%). 
Prostatic abscess characteristics and microbiological da-
ta are shown in Table 1. The average volume of the prostate 
was 56.3 ml (range, 21 to 223 ml), the average PSA was 
18.54 ng/ml (range, 2.0 to 57.0 ng/ml), and the average ab-
scess size was 3.88 cm (range, 2.0 to 6.0 cm). The results 
of the urine culture tests showed that the most common 
pathogens were Escherichia coli (21, 40.4%) followed by 
Klebsiella pneumoniae (9, 17.3%), Pseudomonas aerugino-
sa (8, 15.4%), Staphylococcus aureus (4, 7.7%), and Strep-
tococcus agalactiae (2, 3.8%). 
Prostatic abscesses were treated by conservative treat-
ment (11 cases), transurethral resection of prostatic ab-
scess (23 cases), and TRUS-guided needle aspiration (18 
cases). The average hospitalization stay was 17.5 days 
(range, 6 to 39 days); that of the conservative treatment pa-
tient group was 19.08 days (range, 9 to 39 days). Patients 
treated by transurethral resection of prostatic abscess and 
TRUS-guided needle aspiration stayed 10.22 days (range, 
7 to 21 days) and 23.25 days (range, 6 to 32 days), respec-
tively. Of the 18 cases who underwent needle aspiration, 
prostatic abscesses recurred in 4 cases (22.2%) within 1 
month after discharge from the hospital. The 2 patients 
subjected to conservative treatment died due to sepsis. 
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TABLE 1. Demographic and clinical features of 52 patients with prostatic abscess according to treatment method
 Total
Treatment method
TURP     Needle aspiration     Conservative care
No.
Age (yr)
No. of comorbiditiesa
≤1
≥2
Main clinical symptoms 
Perineal discomfortb
Myalgiab
Feverb
Urinary symptoms
Burning micturitionb
Dysuria
Gross hematuriab
Acute urinary reten-
tionb (500 ml or above)
Urine culture
E. coli
K. pneumonia
P. aerusinosa
Staphyl. aureus
Strepto. agalactiae
Mean PSA 
Mean prostate volume
Mean abscess size
Hospital stay (d)
Recurrence
Death
  52
61.34±11.54 (33–81)
              43 (82.7)
              18 (34.6)
              47 (90.4)
              15 (28.8)
              40 (76.9)
                9 (17.3)
              29 (55.8)
              21 (40.4)
                9 (17.3)
                8 (15.4)
                4 (7.7)
                2 (3.8)
18.54±13.2 (2.0–57)
  56.3±35.4 (21–223)
    3.88±0.9 (2.0–6.0)
  17.5±8.55 (6–39)
                4 (7.6)
                2 (3.8)
23
  66.8±5.4 (33–71)
19 (82.6)
4 (17.4)
20 (87.0) 
6 (26.1) 
23 (100) 
6 (26.1) 
18 (78.3)
4 (17.4)
15 (65.2) 
10 (23.8)
5 (11.9)
 4(9.5)
2 (4.7)
1 (2.3)
14.68±13.9 (2.9–49)
59.41±24.9 (21–108)
3.87±0.38 (3.0–4.0)
10.22±2.81 (6–15)
0 (0)
0 (0)
18
61.34±11.5 (42–78)
            15 (83.3)
              3 (16.7)
            16 (88.9) 
              5 (27.8) 
            16 (88.9)
              4 (22.2) 
            14 (77.8)
              4 (22.2) 
              8 (44.4) 
              7 (16.6)
              3 (7.1)
              2 (4.7)
              1 (2.3)
              1 (2.3)
18.2±10.1 (7.1–39.3)
  41.6±7.8 (24–50)
4.04±0.95 (2.0–5.0)
23.25±5.36 (18–34) 
              4 (22.02)
              0 (0)
11
56.42±12.54 (53–81)
              8 (72.7)
              3 (27.3)
              7 (63.6) 
              7 (63.6) 
              8 (72.7) 
              5 (45.5) 
              8 (72.7)
              1 (9.1) 
              6 (54.5)
              4 (9.0)
              1 (2.3)
              2 (4.7)
              1 (2.3)
              0 (0)
21.65±14.1 (8–57)
64.6±58.0 (24–223)
  3.78±1.2 (3.0–6.0)
19.08±9.59 (9–39) 
              0 (0)
              2 (0.18)
Values are presented as mean±SD (range) or number (%).
TURP, transurethral resection of the prostate; PSA, prostate-specific antigen; E. coli, Escherichia Coli; K. pneumonia, Klebsiella aerusi-
nosa; Staphyl. aureus, Staphylococcus aureus; Strep. agalctiae, Streptochoccus agalctiae.
a:No. of comorbidies ≤1, diabetes mellitus (DM) (-) and hypertension (HTN) (-) and spinal cord injury (-); ≥2, DM (+) or HTN (+) or 
spinal cord injury (+), b:p＜0.05 by Fisher’s exact test.
TABLE 2. Multiple linear regression analysis of hospital stay in 
patients with prostatic abscess 
Variable
Regression 
coefficient 
(R)
Standard 
error
p-valuea
Age 
Abscess size
Prostate volume
Treatment methods
Prostate-specific antigen
0.125
0.750
0.011
1.236
0.108
0.163
2.076
0.048
2.287
0.134
0.450
0.721
0.827
0.594
0.429
a:From final multivariate model after multiple regression 
analysis with stepwise selection of the following covariate: age, 
abscess size, prostate volume, treatment methods and pro-
state-specific antigen.
Age, mean PSA, mean prostate volume, mean abscess 
size, hospital stay, recurrence, and death were examined 
by using the Kruskal-Wallis test with the Dunn post hoc 
test. There was a statistically significant difference 
(p=0.002) in hospital stay (Table 1). On the basis of that re-
sult, the independent factors (age, abscess size, prostate 
volume, treatment methods, and PSA) that could affect 
hospital stay (days) were examined by multiple linear re-
gression analysis. We found no meaningful independent 
factors (Table 2).
DISCUSSION
Prostatic abscess is uncommon because of the wide use of 
broad-spectrum antibiotics in patients with lower urinary 
tract symptoms [11]. When not adequately treated or when 
treatment is delayed, prostatic abscess can progress to sep-
sis and death [3]. Accurate diagnosis and efficient treat-
ment are thus required. However, there is no stand-
ardization of the diagnostic and therapeutic routine for 
prostatic abscess [10,12].
The signs and symptoms of prostatic abscess are rou-
tinely fever, chilling, urinary frequency, acute urinary re-
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tention, dysuria, perineal or lower back pain, and hema-
turia [1,13]. The findings on a digital rectal examination 
can often detect fluctuant mass. The signs, symptoms, and 
results of the physical examination of prostatic abscess are 
similar to those of acute bacterial prostatitis; thus, it is dif-
ficult to diagnosis prostatic abscess alone. However, it is 
very important to distinguish between acute bacterial 
prostatitis and prostatic abscess, because the therapeutic 
approach for each is different [14].
Since the advent of antibiotic therapy, the type of organ-
isms responsible for the development of prostatic abscess 
has changed. In the preantibiotic era, Neisseria gonor-
rhoeae was the primary organism and was responsible in 
75% of cases. In the antibiotic era, gram-negative bacilli 
(chiefly E. coli) have caused about 60% to 80% of cases. 
Other significant pathogens include Pseudomonas species, 
Staphylococcus species, and occasionally obligate anaero-
bic bacteria [1,15].
Numerous factors have been described in the literature 
in association with prostatic abscess formation. It is 
thought that the retrograde flow of contaminated urine 
within the prostate during micturition is the most preva-
lent pathogenic factor. Indwelling catheters, a recent pros-
tate biopsy, and instrumentation of the lower urinary tract 
can be risk factors for prostatic abscess [16]. Bacterial hem-
atogenous spread from distant foci has also been described, 
such as from respiratory (bronchitis, otitis), digestive (ap-
pendicitis, diverticulitis), and urinary tract (perirenal ab-
scess) infections or from the skin (furuncles, abrasions). In 
these cases, germs like S. aureus, Mycobacterium tuber-
culosis, E. coli, and Candida sp. may be found [1].
Prostatic abscess is difficult to diagnosis through the 
signs, symptoms, and physical examination. Prostatic 
imaging study such as TRUS, CT, and magnetic resonance 
imaging is important in the diagnosis and treatment. 
TRUS can be used initially and easily to make a diagnosis 
of prostatic abscess. The most common TRUS finding is one 
or more hypoechoic areas with well-defined and thick walls 
containing thick liquid fluid [17]. TRUS can be interpreted 
variously in other conditions such as neoplastic processes, 
cystic lesions, or granulomas. Thus, in the initial stages of 
abscess formation, it may be inconclusive. TRUS can also 
cause pain to patients, and abscess size may be changed 
with the angle of TRUS. CT of the abdomen and pelvic area 
causes no pain to patients, is less subject to the point of view 
of the inspector, and can help to detect contiguous spread 
of infection in nearby organs [18]. 
Studies of the treatment of prostatic abscess were done 
several decades ago. Ludwig et al. [19] reviewed a series 
of 18 patients and suggested that a monofocal abscess of 
less than 1 cm in diameter be treated with intravenous 
broad-spectrum antibiotic therapy and a suprapubic 
catheter. Surgical drainage should be performed for multi-
focal abscesses greater than 1 cm in diameter, septic shock, 
recurrent abscess, or in patients responding poorly to anti-
biotics for 3 days or longer. Traditionally, open perineal in-
cision or transurethral resection was recommended as the 
method of choice [5,6].
Nowadays, minimally invasive treatment such as 
TRUS-guided needle aspiration or drainage via tube trans-
perineally or transrectally under local anesthesia or seda-
tion is preferred. First, Becker and Harrin [4] reported that 
needle aspiration with adjuvant antibiotic therapy could 
produce a cure, and many clinicians researched the effec-
tiveness of needle aspiration. Collado et al. [8] reported 
that 20 of 24 patients treated with TRUS-guided needle as-
piration and adjuvant antibiotic therapy were successfully 
treated. Gan [9] suggested that TRUS-needle aspiration is 
a feasible alternative to transurethral drainage. Lim et al. 
[10] reported successful treatment of prostatic abscess in 
12 of 14 patients with TRUS-guided needle aspiration. 
Aravantinos et al reported that TRUS-guided placement 
of a transrectal drainage tube is a feasible, safe, and effec-
tive alternative to standard methods of treatment with 
good therapeutic results [3].
However, there are few reports comparing the treatment 
of prostate abscess according to modalities. In this study, 
three treatment methods of prostate abscess were re-
viewed and the outcomes were compared. Patients who un-
derwent transurethral resection of the prostate had a sig-
nificantly shorter hospitalization length compared with 
that in the other two groups, but it can’t be said that tran-
surethral resection of the prostate (TURP) is a superior 
method because it is an invasive procedure that requires 
general anesthesia and may have surgical complications. 
Among patients who underwent needle aspiration, 4 of 18 
patients experienced recurrence within 1 month from hos-
pital discharge. Unexpectedly, patients treated by needle 
aspiration had a significantly longer hospitalization stay 
than did those who were conservatively treated. We don’t 
know the reason for this result. It may be that other factors 
need to be considered. Two patients died during con-
servative treatment. Although there were significant fac-
tors, these patients were relatively old, 71 and 76 years old, 
and it may be that more active treatment should be consid-
ered for elderly patients with prostate abscess.
This study had the limitation that it was not a controlled 
study and thus there may be other clinical factors affecting 
the clinical outcomes that were not taken into account. 
CONCLUSIONS
Prostatic abscess is not a common disease but may result 
in mortality; thus, prompt diagnosis and interventional 
treatment is required. In this study, patients treated by 
TURP had a significantly shorter hospitalization length, 
and there were no cases of recurrence or mortality. Needle 
aspiration resulted in the longest hospitalization and high 
recurrence. Because there were limitations to this study, 
these results may be considered when a patient presents 
with prostate abscess.
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